Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 7, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for April 24, 2008 Subscribe to this News Feed      
 

NuSil Technology Introduces Water-Resistant Dimethicone for Pharmaceutical, Cosmeceutical Applications

NuSil Technology, a cutting-edge manufacturer of silicone compounds for the healthcare, drug delivery and pharmaceutical industries, announced the launch of its MED-323 dimethicone product. The product reinforces NuSil's commitment to the pharmaceutical and cosmeceutical industries.

Carpinteria, CA (PRWEB) April 24, 2008 -- NuSil Technology, a cutting-edge manufacturer of silicone compounds for the healthcare, drug delivery and pharmaceutical industries, announced the launch of its MED-323 dimethicone product. The product reinforces NuSil's commitment to the pharmaceutical and cosmeceutical industries.

MED-323, a tri-methyl endblocked polydimethylsiloxane, may be considered as an excipient for cosmetic and pharmaceutical applications and offers excellent water repellency in topical skin and hair care products. It meets the requirements of the United States Pharmacopeia National Formulary (NF) and European Pharmacopeia (EP) for a dimethicone at 350 cSt viscosity. In addition, the product is produced in NuSil's FDA-registered manufacturing site.

"NuSil's acquisition of the Simethicone product line in 2004 marked the beginning of the company's commitment to the industry," said Brian Nash, vice president of Marketing and Sales. "With exemplary products, such as MED-323, NuSil Technology unwavers in its support of the pharmaceutical industry."

A masterfile for MED-323 will be filed with the United States Food and Drug Administration, and customers interested in authorization to reference the masterfile should contact NuSil Technology directly. MED-323 is available in 5-gallon and 55-gallon quantities.
For more information, visit www.nusil.com or call 805-684-8780.

About NuSil Silicone Technology:
NuSil is a cutting-edge manufacturer of silicone compounds for healthcare, aerospace, electronics, photonics and other applications requiring precise, predictable, cost-effective materials performance. ISO-9001-certified since 1994, NuSil operates state-of-the-art laboratories and processing facilities in North America and Europe and provides on-site, in-person application engineering support worldwide. More information about NuSil Technology can be found at www.nusil.com.

###

Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
KRISTEN THOMAS
NuSil Technology
310-752-4400
Email us Here
Steve Bruner
NuSil Technology
805-566-4130
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright